Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC

Clinical trial NCT06598761 · RECRUITING

Trial details

NCT number: NCT06598761
Sponsor: Peking University First Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Ureter Cancer Renal Pelvic Carcinoma Advanced Urothelial Carcinoma

Start date: 2022-01-01
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.